A recent study conducted by Hee Noh, et al. has shown that NANOG activates AKT signaling via T cell leukemia /protein 1a (Tol 1A) which, in turn, promotes a stem cell-like phenotype and immune evasion in cancer cells [28]. Here, AKT1 is linked to cancer.